Literature DB >> 19454437

Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

F Pacini1, M G Castagna, L Brilli, G Pentheroudakis.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454437     DOI： 10.1093/annonc/mdp156

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  15 in total

1.  Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.

Authors:  Qing Xia; Shuai Dong; Ping-Da Bian; Jue Wang; Cheng-Jiang Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-06       Impact factor: 2.503

2.  Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases.

Authors:  Alexandre Bozec; Olivier Dassonville; Emmanuel Chamorey; Gilles Poissonnet; Anne Sudaka; Isabelle Peyrottes; Francette Ettore; Juliette Haudebourg; Françoise Bussière; Danielle Benisvy; Pierre-Yves Marcy; Jean Louis Sadoul; Paul Hofman; Sandra Lassale; Jacques Vallicioni; François Demard; José Santini
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-24       Impact factor: 2.503

3.  Systemic Endoradiotherapy with Carrier-Added 4-[(131)I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory Glioma.

Authors:  Richard P Baum; Andreas Kluge; Franz Josef Gildehaus; Marcus Bronzel; Karl Schmidt; Christiane Schuchardt; Stephan Senftleben; Samuel Samnick
Journal:  Nucl Med Mol Imaging       Date:  2011-11-16

4.  Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.

Authors:  Amir Sabet; Ina Binse; Semih Dogan; Andrea Koch; Sandra J Rosenbaum-Krumme; Hans-Jürgen Biersack; Kim Biermann; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-16       Impact factor: 9.236

5.  Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.

Authors:  S Jang; X-M Yu; S Odorico; M Clark; R Jaskula-Sztul; C M Schienebeck; K R Kupcho; A D Harrison; G N Winston-McPherson; W Tang; H Chen
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

Review 6.  The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.

Authors:  Anthony R Glover; Justin S Gundara; Olov Norlén; James C Lee; Stan B Sidhu
Journal:  Gland Surg       Date:  2013-11

7.  Patterns of structural recurrence in papillary thyroid cancer.

Authors:  Schelto Kruijff; Japke F Petersen; Paul Chen; Ahmed M Aniss; Roderick J Clifton-Bligh; Stan B Sidhu; Leigh W Delbridge; Anthony J Gill; Diana Learoyd; Mark S Sywak
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

8.  Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.

Authors:  Amir Sabet; Ina Binse; Hong Grafe; Samer Ezziddin; Rainer Görges; Thorsten D Poeppel; Andreas Bockisch; Sandra J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-27       Impact factor: 9.236

9.  THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER.

Authors:  B I Aydoğan; C C Ersöz; S D Sak; S Güllü
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

10.  Controversies in the management and followup of differentiated thyroid cancer: beyond the guidelines.

Authors:  Hala Ahmadieh; Sami T Azar
Journal:  J Thyroid Res       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.